Gothamist

A non-profit newsroom, powered by WNYC.

Gothamist

WNYC Listen Live

Donate

 

 

News

White House Overrules FDA To Keep Restrictions On Plan B


By

Jen Chung

Published Dec 7, 2011

Modified Dec 7, 2011


Share

FacebookTwitterRedditEmail


Never miss a story

 Email address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .


By

Jen Chung

Published Dec 7, 2011

Modified Dec 7, 2011


Share

FacebookTwitterRedditEmail


We rely on your support to make local news available to all

Make your contribution now and help Gothamist thrive in 2026. Donate today

Gothamist is funded by sponsors and member donations

Today, the Food and Drug Administration decided to make Plan B, the morning-after contraceptive, available to everyone and lift the requirement that those under 17 years of age need a prescription. However, Health and Human Services Kathleen Sebelius rejected the decision, which means access is still restricted. Sebelius's statement says, "The science has confirmed the drug to be safe and effective with appropriate use. However, the switch from prescription to over the counter for this product requires that we have enough evidence to show that those who use this medicine can understand the label and use the product appropriately. I do not believe that [Plan B maker] Teva’s application met that standard. The label comprehension and actual use studies did not contain data for all ages for which this product would be available for use."

The NY Times reports, "Under the law, Ms. Sebelius has the authority to overrule the agency, but no health secretary has ever done so, according to an F.D.A. spokeswoman. Her decision on an emotional issue that touches on parental involvement in birth control for teenaged children is likely to have powerful political reverberations in a presidential election season."

FDA Administrator Margaret A. Hamburg said, "I agree ... there is adequate and reasonable, well-supported, and science-based evidence that Plan B One-Step is safe and effective and should be approved for nonprescription use for all females of child-bearing potential.. However, this morning I received a memorandum from the Secretary of Health and Human Services invoking her authority under the Federal Food, Drug, and Cosmetic Act to execute its provisions and stating that she does not agree with the Agency’s decision to allow the marketing of Plan B One-Step nonprescription for all females of child-bearing potential."

Advocacy group Reproductive Health Technologies Project's Kirsten Moore told the Washington Post, "We are outraged that this administration has let politics trump science. There is no rationale for this move. This is unprecedented as evidenced by the commissioner’s own letter. Unbelievable."

Tagged

emergency contraception

fda

kathleen sebelius

Plan B

White House

women's rights


Jen Chung

Jen Chung is a former WNYC and Gothamist editor.

Read more

Gothamist is funded by sponsors and member donations


Gothamist is funded by sponsors and member donations


MORE news

Owner of Peanut, scandalously slain NY squirrel, charged with upstate mortgage fraud

Mark Longo, 36, was arraigned on 14 felony counts.

By

Jon Campbell

Published Nov 18, 2026 at 8:44 p.m. ET


City to demolish Brooklyn building damaged in deadly Flatbush collapse

City engineers say the neighboring apartment building is too unstable to repair safely.

By

Phil Corso

News

City to demolish Brooklyn building damaged in deadly Flatbush collapse

City engineers say the neighboring apartment building is too unstable to repair safely.

By

Phil Corso


Trump said congestion pricing would end NYC. Now, his admin wants it in more cities.

By

Stephen Nessen

MTA warns of major budget deficit without help from city, state and feds

By

Ramsey Khalifeh

NYPD investigating alleged sexual assault of NYU student near freshman dorm

By

Giulia Heyward


Never miss a story

Catch up on the most important headlines with a roundup of essential NYC stories, delivered to your inbox daily.

Sign upEmail address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .